Identification of tumor specific immunogenic mutations as potential immunotherapeutic targets
Recruiting
- Conditions
- C18C34C56C80.9C82C06C19C13C20C10
- Registration Number
- DRKS00009977
- Lead Sponsor
- Berliner Institut für GesundheitsforschungKörperschaft des öffentlichen Rechts
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Histologically proven carcinoma, among others mainly carcinomas of the lung, colon and ovar or histologically proven lymphoma, age above 18 years, written informed consent
Exclusion Criteria
HIV, HBV, HCV, limited legal capacitiy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of immunogenic mutations for development of T cell based immunptherapies at first diagnosis or relaps using molecular biological, protein biochemical and cell biological methods
- Secondary Outcome Measures
Name Time Method